Evidence map›Paper›PMID 32087606›Full record

ArticleCNS neuroscience & therapeutics2020

Cerebral organoids transplantation improves neurological motor function in rat brain injury.

Zhi Wang, Shu-Na Wang, Tian-Ying Xu, Chen Hong, Ming-He Cheng, Peng-Xi Zhu, Jian-Sheng Lin, Ding-Feng Su, Chao-Yu Miao

Open access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Organoid Brain-Machine-Interface Devices for Central Nervous System Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Innovative approaches for the treatment of stroke: a recent update.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zhi WangDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.
Shu-Na WangDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.ORCID 0000-0002-3091-1281
Tian-Ying XuDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.
Chen HongDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.
Ming-He ChengDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.
Peng-Xi ZhuDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.
Jian-Sheng LinIntegrative Physiology of the Brain Arousal Systems, CRNL, INSERM U1028-CNRS UMR 5292, School of Medicine, Claude Bernard University, Lyon, France.ORCID 0000-0002-2004-6079
Ding-Feng SuDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.
Chao-Yu MiaoDepartment of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China.ORCID 0000-0002-8176-3434
Second Military Medical University · CNUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeCerebral organoids (COs) have been used for studying brain development, neural disorders, and species-specific drug pharmacology and toxicology, but the potential of COs transplantation therapy for brain injury remains to be answered.

methodsWith preparation of traumatic brain injury (TBI) model of motor dysfunction, COs at 55 and 85 days (55 and 85 d-CO) were transplanted into damaged motor cortex separately to identify better transplantation donor for brain injury. Further, the feasibility, effectiveness, and underlying mechanism of COs transplantation therapy for brain injury were explored.

results55 d-CO was demonstrated as better transplantation donor than 85 d-CO, evidenced by more neurogenesis and higher cell survival rate without aggravating apoptosis and inflammation after transplantation into damaged motor cortex. Cells from transplanted COs had the potential of multilinage differentiation to mimic in-vivo brain cortical development, support region-specific reconstruction of damaged motor cortex, form neurotransmitter-related neurons, and migrate into different brain regions along corpus callosum. Moreover, COs transplantation upregulated hippocampal neural connection proteins and neurotrophic factors. Notably, COs transplantation improved neurological motor function and reduced brain damage.

conclusionsThis study revealed 55 d-CO as better transplantation donor and demonstrated the feasibility and efficacy of COs transplantation in TBI, hoping to provide first-hand preclinical evidence of COs transplantation for brain injury.

Indexed as

AnimalsBrain InjuriesBrain Tissue TransplantationCell MovementCells, CulturedEmbryonic Stem CellsHumansMaleMotor SkillsMotor Skills DisordersNeurogenesisOrganoidsRatsRats, Sprague-Dawleybrain injurycerebral organoidsfunctional recoveryneural repairtransplantation

Identifiers

PMID32087606
PMCPMC7298981
OpenAlexW3008881581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.